DATA INSIGHTS

ASX 200 stocks hitting fresh 52-week highs and lows – Week 18

Healthcare takes a beating as Cochlear's 40% plunge drags peers lower, while February's earnings season still haunts discretionary names.

Lead Writer
Mon 27 Apr 2026, 11:22 AEST
3 min read
ASX 200 stocks hitting fresh 52-week highs and lows – Week 18

Source: Shutterstock

Mentioned

Welcome back to the 52-Week Series, where we recap the S&P/ASX 200 stocks that have hit fresh yearly highs and lows over the past week. Tracking this data point helps identify emerging trends across various stocks and sectors.

When clusters of stocks within a sector reach new highs or lows, it often points to meaningful underlying drivers such as shifting commodity prices, changing demand patterns (such as AI, pivots into defensive sectors, consumer weakness etc), or companies beating/missing earnings expectations.

52-Week highs and lows by sector

  • Materials: 4 Highs, 0 Lows

  • Energy: 2 Highs, 0 Lows

  • Financials: 1 High, 2 Lows

  • Discretionary: 1 High, 5 Lows

  • Staples: 1 High, 0 Lows

  • Industrials: 0 Highs, 3 Lows

  • Health Care: 0 Highs, 5 Lows

  • Utilities: 0 Highs, 0 Lows

  • Technology: 0 Highs, 0 Lows

  • Real Estate: 0 Highs, 0 Lows

  • Telecommunications: 0 Highs, 0 Lows

What Does the Data Tell Us?

  • Healthcare takes a leg down: A brutal week for healthcare stocks, headlined by Cochlear's 40.7% single-day selloff on Wednesday after it cut FY26 underlying net profit guidance by roughly 30% (from $435-460m to $290-330m), citing deteriorating trading conditions in the US and Europe. What's interesting is that peers like CSL and ResMed also tumbled on the day, down 5.7% and 2.4% respectively, despite no company-specific news, suggesting the read-through went sector-wide. Healthcare recorded five 52-week lows for the week, and the S&P/ASX 200 Healthcare Index is now down 23% year-to-date, sitting at its lowest level since April 2018.

  • Discretionary softness: Four of the five discretionary names that hit yearly lows last week share a common catalyst. All sold off sharply on weaker-than-expected 1H26 results back in February:

    • Temple & Webster down 32.6% on 12-Feb

    • ARB down 13.0% on 24-Feb

    • Nick Scali down 22.0% on 13-Feb

    • Harvey Norman down 9.0% on 27-Feb

    • Super Retail up 8.3% on 26-Feb

  • Zooming out: A relatively low volume of 52-week highs and lows, as the ASX 200 still 5% above the recent 23 March low and within 5% of its all-time highs.

ASX 200 stocks at 52-week highs

Ticker
Company
Close
Sector
1 Week
1 Year
Liontown
$2.24
Materials
1.8%
293.0%
PLS Group
$5.77
Materials
-4.5%
274.7%
Predictive Discovery
$0.96
Materials
2.7%
158.1%
Paladin Energy
$12.61
Energy
-13.3%
105.7%
Tabcorp
$1.11
Discretionary
10.5%
94.7%
Karoon Energy
$2.24
Energy
4.7%
56.6%
Rio Tinto
$171.59
Materials
-1.2%
47.2%
Woolworths Group
$37.89
Staples
3.0%
19.8%
Macquarie Group
$232.28
Financials
-3.2%
19.5%
S&P/ASX 200 stocks and sectors that hit a 52-week high in the past week, sorted by one-year returns. Data as at Friday, 24 April 2026.

ASX 200 stocks at 52-week lows

Ticker
Company
Close
Sector
1 Week
1 Year
Temple & Webster Group
$5.86
Discretionary
-12.0%
-67.2%
ARB Corporation
$19.54
Discretionary
-5.6%
-38.3%
Nick Scali
$14.93
Discretionary
-4.5%
-15.2%
Harvey Norman
$4.53
Discretionary
-0.9%
-13.2%
Super Retail Group
$12.19
Discretionary
-2.4%
-7.9%
Judo Capital
$1.40
Financials
-7.0%
-20.2%
Generation Development Group
$3.61
Financials
-18.3%
-13.6%
Cochlear
$97.35
Health Care
-42.2%
-64.1%
CSL
$130.00
Health Care
-5.2%
-47.0%
Resmed Inc
$30.89
Health Care
-2.0%
-16.0%
Ansell
$26.76
Health Care
-1.4%
-10.8%
Fisher & Paykel
$29.42
Health Care
-5.8%
-8.5%
Fletcher Building
$2.30
Industrials
-2.5%
-21.0%
Atlas Arteria
$4.33
Industrials
1.4%
-15.6%
Austal
$4.62
Industrials
-0.2%
-10.1%
S&P/ASX 200 stocks and sectors that hit a 52-week low in the past week, sorted by sector and one-year returns. Data as at Friday, 24 April 2026.

ABOUT THE AUTHOR

Lead Writer

Kerry holds a Bachelor of Commerce from Monash University. He is passionate about equity research and trading (swing and intraday), with a focus on breaking down market-related catalysts into clear, contextual insights and developing data-driven market biases.

28/06/2026